The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,736.00
Bid: 1,718.00
Ask: 1,732.00
Change: 32.00 (1.88%)
Spread: 14.00 (0.815%)
Open: 1,684.00
High: 1,736.00
Low: 1,684.00
Prev. Close: 1,704.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Seeing Increased Demand As African Swine Fever Ravages China

Thu, 14th Nov 2019 09:26

(Alliance News) - Animal genetics firm Genus PLC on Thursday said the African swine fever crisis in China has led to increased demand.

China, and some neighbouring countries, have been grappling with an outbreak of the disease since August 2018, which has led to large number of pigs, at least over one million, being culled.

Last weekend, data from China showed the price of pork in October, the staple meat in the country, more than doubled over the past year.

"Pork prices in China have continued to increase due to the impact of African swine fever, which is now resulting in increased demand for Genus's genetics," said the company.

"The threat of ASF still remains for producers in the region. While we continue to closely monitor its spread to the Philippines and other parts of south-east Asia, we expect PIC Asia to increase profits in financial 2020 compared with the prior year," said Basingstoke, Hampshire-based Genus.

Overall trading in the four months to October 31 continued to be solid, Genus said, with volume, revenue, and adjusted operating profit rising in both pork business PIC and beef unit ABS. Adjusted pretax profit for the group showed "good growth" year-on-year.

Genus said the adoption and sale of Sexcel, a product designed to improve animal breeding, continues to rapidly expand.

"The board currently anticipates that Genus will continue to make strategic and financial progress and perform in line with its growth expectations for the financial year 2020," Genus added.

Genus's current financial year ends June 2020. Shares were 0.2% higher on Thursday morning in London at 3,151.00 pence each.

By George Collard; georgecollard@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
22 Jun 2021 20:34

IN BRIEF: Genus trial shows gene edited pigs resistant to PRRS virus

IN BRIEF: Genus trial shows gene edited pigs resistant to PRRS virus

Read more
22 Jun 2021 07:50

Genus provides update on PRRS virus resistance programme

(Sharecast News) - Animal genetics company Genus provided an update on its porcine reproductive and respiratory syndrome virus resistance programme as part of its capital markets event on Tuesday.

Read more
31 Mar 2021 17:13

DIRECTOR DEALINGS: Sealand Capital chair invests amid licence talks

DIRECTOR DEALINGS: Sealand Capital chair invests amid licence talks

Read more
31 Mar 2021 12:17

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

Read more
31 Mar 2021 09:37

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

Read more
25 Mar 2021 16:03

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
22 Mar 2021 14:07

IN BRIEF: Genus adds molecular biology head Jason Chin to board

IN BRIEF: Genus adds molecular biology head Jason Chin to board

Read more
26 Feb 2021 16:23

DIRECTOR DEALINGS: Hochschild, Wizz Air, Clipper Logistics Execs Sell

DIRECTOR DEALINGS: Hochschild, Wizz Air, Clipper Logistics Execs Sell

Read more
25 Feb 2021 17:04

LONDON MARKET CLOSE: Stocks Edge Lower As US Bond Yields Rise

LONDON MARKET CLOSE: Stocks Edge Lower As US Bond Yields Rise

Read more
25 Feb 2021 16:15

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
25 Feb 2021 13:49

Thursday broker round-up

(Sharecast News) - Medica Group: Liberum initiates at buy with a target price of 200p.

Read more
25 Feb 2021 12:04

LONDON MARKET MIDDAY: Stocks Notch Moderate Gains Ahead Of US Data

LONDON MARKET MIDDAY: Stocks Notch Moderate Gains Ahead Of US Data

Read more
25 Feb 2021 09:42

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Read more
25 Feb 2021 09:33

BROKER RATINGS: AstraZeneca, Reckitt And Tesco Receive Upgrades

BROKER RATINGS: AstraZeneca, Reckitt And Tesco Receive Upgrades

Read more
25 Feb 2021 09:05

Genus reports strong interim results

(Sharecast News) - Animal genetics company Genus reported a record adjusted profit before tax in its interim results on Thursday, as revenue in its porcine genetics business 'PIC' rose 8%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.